Ads
related to: Abbvie
Search results
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
AOL· 10 hours agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent ...
REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Reuters via Yahoo Finance· 11 hours ago(Corrects to remove extraneous text and to add Regeneron ticker symbol) April 25 (Reuters) - AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory ...
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 3 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy By Reuters
Investing.com· 2 hours agoCigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers...
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 days agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 6 days agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
Can a new batch of tech earnings rescue the market? Here are the factors at play
CNBC· 4 hours agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 2 days agoHere are their earnings season movers. 9 more stocks with positive earnings catalysts AbbVie...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 6 days agoAccording to data collected by Iqvia, the number of prescriptions of Novartis' (NVS) Hyrimoz has...